发明授权
EP1370268B1 METHODS FOR TREATING STRESS DISORDERS USING GLUCOCORTICOID RECEPTOR-SPECIFIC ANTAGONISTS
有权
法与压力有关的疾病的治疗中使用糖皮质激素REZEPTO特异性拮抗剂
- 专利标题： METHODS FOR TREATING STRESS DISORDERS USING GLUCOCORTICOID RECEPTOR-SPECIFIC ANTAGONISTS
- 专利标题（中）： 法与压力有关的疾病的治疗中使用糖皮质激素REZEPTO特异性拮抗剂
-
申请号： EP02725270.9申请日： 2002-03-19
-
公开(公告)号： EP1370268B1公开(公告)日： 2009-07-15
- 发明人: BELANOFF, Joseph, K.
- 申请人： Corcept Therapeutics, Inc.
- 申请人地址： 149 Commonwealth Avenue Menlo Park, CA 94025 US
- 专利权人： Corcept Therapeutics, Inc.
- 当前专利权人： Corcept Therapeutics, Inc.
- 当前专利权人地址： 149 Commonwealth Avenue Menlo Park, CA 94025 US
- 代理机构： Sexton, Jane Helen
- 优先权： US278523P 20010323
- 国际公布： WO2002076390 20021003
- 主分类号： A61K31/59
- IPC分类号： A61K31/59 ; A61K31/56 ; A61P25/18
摘要：
This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for treating stress disorders. Mifepristone, a potent specific glucocorticoid receptor antagonist, can be used in these methods. The invention also provides a kit for treating stress disorders in a human including a glucocorticoid receptor antagonist and instructional material teaching the indications, dosage and schedule of administration of the glucocorticoid receptor antagonist.
公开/授权文献
信息查询
